Greg J Divis - Net Worth and Insider Trading
Greg J Divis Net Worth
The estimated net worth of Greg J Divis is at least $3 Million dollars as of 2024-04-28. Greg J Divis is the CEO of Avadel Pharmaceuticals PLC and owns about 159,100 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $3 Million. Details can be seen in Greg J Divis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Greg J Divis has not made any transactions after 2023-08-10 and currently still holds the listed stock(s).
Transaction Summary of Greg J Divis
Greg J Divis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Greg J Divis owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and Jaguar Health Inc (JAGX) .
Click here to see the complete history of Greg J Divis’s form 4 insider trades.
Insider Ownership Summary of Greg J Divis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-08-10 | director & Chief Executive Officer |
| JAGX | Jaguar Health Inc | 2018-06-14 | director |
Greg J Divis Latest Holdings Summary
Greg J Divis currently owns a total of 1 stock. Greg J Divis owns 159,100 shares of Avadel Pharmaceuticals PLC (AVDL) as of August 10, 2023, with a value of $3 Million.
Latest Holdings of Greg J Divis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-08-10 | 159,100 | 17.81 | 2,833,571 |
Holding Weightings of Greg J Divis
Greg J Divis Form 4 Trading Tracker
According to the SEC Form 4 filings, Greg J Divis has made a total of 4 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 10,000 shares on August 10, 2023, which cost Greg J Divis around $132,000.
Insider Trading History of Greg J Divis
- 1
Greg J Divis Trading Performance
GuruFocus tracks the stock performance after each of Greg J Divis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Greg J Divis is 22.19%. GuruFocus also compares Greg J Divis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Greg J Divis within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Greg J Divis's insider trading performs compared to the benchmark.
Performance of Greg J Divis
Average Return
76.85%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.59 | 22.19 | 35.75 | 76.85 | 1.27 | 7.39 |
| Relative Return to S&P 500(%) | 3.54 | 18.4 | 32.48 | 62.71 | -11.21 | -3.79 |
Greg J Divis Ownership Network
Ownership Network List of Greg J Divis
Ownership Network Relation of Greg J Divis
Greg J Divis Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Greg J Divis is the director & Chief Executive Officer of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , Chief Commercial Officer Richard J Kim , and Chief Medical Officer Douglas J Williamson .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Greg J Divis made 1 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 10,000. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Greg J Divis Mailing Address
Above is the net worth, insider trading, and ownership report for Greg J Divis. You might contact Greg J Divis via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
